{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T23:05:59Z","timestamp":1648854359987},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1097\/md.0000000000005422","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T12:56:28Z","timestamp":1479992188000},"page":"e5422","source":"Crossref","is-referenced-by-count":3,"title":["Combination of transcatheter arterial chemoembolization and CT-guided percutaneous segment ablation for hepatocellular carcinoma therapy"],"prefix":"10.1097","volume":"95","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-31-20210309","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-31-20210309","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2217\/fon.13.171","article-title":"Systemic therapies in hepatocellular carcinoma: present and future","volume":"9","author":"Bertino","year":"2013","journal-title":"Future Oncol"},{"key":"R3-31-20210309","doi-asserted-by":"crossref","first-page":"203693","DOI":"10.1155\/2014\/203693","article-title":"Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies","volume":"2014","author":"Bertino","year":"2014","journal-title":"Biomed Res Int"},{"key":"R4-31-20210309","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"R5-31-20210309","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/cncr.28730","article-title":"The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review","volume":"120","author":"Fong","year":"2014","journal-title":"Cancer"},{"key":"R6-31-20210309","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1245\/s10434-012-2705-8","article-title":"Short and long-term outcomes after laparoscopic and open hepatectomy for hepatocellular carcinoma: a global systematic review and meta-analysis","volume":"20","author":"Yin","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R7-31-20210309","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"Management of hepatocellular carcinoma.","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"R8-31-20210309","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/j.jhep.2015.02.007","article-title":"Liver cancer: approaching a personalized care","volume":"62","author":"Bruix","year":"2015","journal-title":"J Hepatol"},{"key":"R9-31-20210309","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"R10-31-20210309","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrclinonc.2014.237","article-title":"Image-guided ablation of primary liver and renal tumours","volume":"12","author":"Breen","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"R11-31-20210309","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1245\/s10434-011-1831-z","article-title":"Efficacy of surgical microwave therapy in patients with unresectable hepatocellular carcinoma","volume":"18","author":"Itoh","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R12-31-20210309","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/MEG.0b013e328318ed04","article-title":"Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review","volume":"21","author":"Ong","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R13-31-20210309","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jhep.2012.01.008","article-title":"Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design","volume":"56","author":"Burrel","year":"2012","journal-title":"J Hepatol"},{"key":"R14-31-20210309","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.3748\/wjg.v21.i12.3462","article-title":"Management of hepatocellular carcinoma with portal vein thrombosis","volume":"21","author":"Quirk","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R15-31-20210309","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jhep.2012.09.003","article-title":"Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression","volume":"58","author":"Memon","year":"2013","journal-title":"J Hepatol"},{"key":"R16-31-20210309","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2214\/AJR.14.12509","article-title":"Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings","volume":"204","author":"Granata","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"R17-31-20210309","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.21980","article-title":"Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"Kulik","year":"2008","journal-title":"Hepatology"},{"key":"R18-31-20210309","first-page":"873601","article-title":"A lethal complication after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma","volume":"2015","author":"Toro","year":"2015","journal-title":"Case Rep Surg"},{"key":"R19-31-20210309","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2482-14-40","article-title":"Effect of pre- and post-treatment alpha-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study","volume":"14","author":"Toro","year":"2014","journal-title":"BMC Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:37:53Z","timestamp":1620959873000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201611220-00031"}},"subtitle":["A retrospective study"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":19,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005422","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}